The Mission
About FibiOS
The intelligence layer for the UK AI-biotech ecosystem. We decode the science, the rules, and the systems that are rewriting medicine.
"Biology is now a readable language. FibiOS exists to translate what that means for the people who will live inside its consequences."
We are a publication. Not a laboratory, not a company, not a movement. We read the primary literature, verify the numbers, and write about what the evidence supports.
We serve the reader who is intelligent but not necessarily a biologist: the clinician tracking a field moving under her feet, the founder who needs the mechanism not the pitch, the investor who wants to know where the regulatory bottlenecks are, and the student deciding what to study.
What we hold to
The Law of Artifacts
A number appears here only if it can be traced to a primary source. Where we cannot verify, we write what is true at the level of confidence the evidence allows.
Primacy of Mechanism
A result without a mechanism is a rumor with a p-value. We explain how a thing works, or we say plainly that it is not yet known.
Restraint
The field does not lack for enthusiasm. It lacks for proportion. We will not sell a decade of biology as a product launch.
The Chora (The Middle Ground)
The Space Between
We acknowledge the vast gap between a model that works in a lab and a therapy that works in a patient. We treat machine learning as a hypothesis generator, not a cure.
Nuance over Noise
A trial result is not a headline. We read the confidence intervals, the p-values, and the limitations. An effect size of 98.4 ml is meaningless without the baseline.
"It is not yet known"
This is a phrase we use often. Acknowledging the boundary of current evidence is not a failure of rigor; it is the definition of it. Where the record is thin, FibiOS says so and stops.
What we refuse
No Prophecy
We do not publish aphorism, decree, or prophecy.
No Medical Advice
Nothing here is a substitute for a clinician who has examined you.
No Pay-for-Play
We do not accept payment to place a claim in an article.
No Spin
We do not report a trial outcome differently because a company would prefer it reported that way.